Compounded tirzepatide
Sold by Rewinding RX · every compounded tirzepatide record
The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.
What you actually pay
Per month
$189
| Medication · Standard dose, flat monthly price, any dose level | $189 |
|---|
Added from the figures recorded below.
Price
| Term | Per month | Charged today |
|---|---|---|
| Standard dose, flat monthly price, any dose level “Tirzepatide $189 / month Average 20% body weight lost - strongest result available” | Per month$189 | Charged today$189 |
We earn nothing from this link. Rewinding RX has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.
History
One reading so far. A price history appears here after the next verification pass.
- September 2, 2026 — Entry added to the register
Sourcing and terms
| States | All 50 states |
|---|---|
| Prescriber | Asynchronous review |
| Cancellation | “Can I stop at any time? Yes. There is no obligation to continue.” |
Not yet checked: pharmacy, membership and consult fee.
Recorded from rewinding.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.
Notes
- 1. September 2, 2026 — Pricing is explicitly presented as flat/all-inclusive ('One flat monthly price', 'Medical oversight included', 'All supplies and program support', 'No surprise cost jumps as dosing increases'), so the perMonth figures above are treated as the full program price, not a membership fee. Refund policy states prescription medications are not returnable/refundable once shipped ('we do not accept returns for unopened products... We do not offer refunds for unopened or unused prescription medications'), separate from the ability to cancel the subscription going forward.
Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.